. Show Affiliations »
Abstract
Mesh: See more » Fibrinolytic Agents/therapeutic useHeparin/administration & dosageHeparin/therapeutic useHumansInfusions, Intra-ArterialRecombinant Proteins/administration & dosageRecombinant Proteins/therapeutic useStroke/drug therapyThrombolytic Therapy/adverse effectsThrombolytic Therapy/standardsTime FactorsTissue Plasminogen Activator/administration & dosageTissue Plasminogen Activator/therapeutic useTreatment OutcomeUrokinase-Type Plasminogen Activator/administration & dosageUrokinase-Type Plasminogen Activator/therapeutic use
Substances: See more » Fibrinolytic AgentsRecombinant ProteinsHeparinTissue Plasminogen ActivatorUrokinase-Type Plasminogen Activatorsaruplase
Year: 2001 PMID: 11686069 PMCID: PMC8172376
Source DB: PubMed Journal: AJNR Am J Neuroradiol ISSN: 0195-6108 Impact factor: 3.825